Expertise in
3
conditions

Gongxian F. Wang

Jiangxi Provincial Key Laboratory Of Urinary System Diseases, 
Nanchang, CN 
Expertise in
3
conditions
Jiangxi Provincial Key Laboratory Of Urinary System Diseases, 
Nanchang, CN 

Overview

Gongxian Wang practices practicing medicine in Nanchang, China.

Wang is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Kidney Stones, Bladder Cancer, Renal Cell Carcinoma (RCC), Lithotripsy, and Ureteroscopy.

They are actively involved in clinical research, co-authoring 102 peer reviewed articles and participating in 3 clinical trials.

Locations

Jiangxi Provincial Key Laboratory Of Urinary System Diseases, Nanchang, 330006, China
Other Locations
Jiangxi, 330006, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 07, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Abiraterone Acetate, Prednisone
Study Phase: Phase 2/Phase 3
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

102 Total Publications

Correction: A novel preoperative risk score for predicting Urosepsis after percutaneous nephrolithotomy: validation and clinical application.
Correction: A novel preoperative risk score for predicting Urosepsis after percutaneous nephrolithotomy: validation and clinical application.
Journal: Urolithiasis
Published: January 31, 2026

Frequently Asked Questions about Gongxian F. Wang

Is Gongxian F. Wang a top-rated expert for Lithotripsy?

MediFind is an objective health platform that identifies experts based on real-world data. Gongxian F. Wang is classified as an Advanced expert for Lithotripsy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gongxian F. Wang participate in research or clinical trials?

Yes. Gongxian F. Wang has published 102 articles and abstracts on conditions like Lithotripsy. You can view a list of Gongxian F. Wang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Wang's expertise for a condition
ConditionClose
      View All 20 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile